Devicare raises USD$3M in a Series A funding led by Advanced MedTech. Ship2B, Emesa and Juan Knuth participate in the round
We are happy to announce that our colleagues from Devicare have closed a USD$3M Series A funding that will advance the development of Lit-Control, a non-surgical solution to kidney stones. Inveniam has advised in the round and the closing of the investment of Ship2B.